SupplySide West 2019 Preview: DolCas to debut a marine-based tripeptide collagen hydrolysate

September 16, 2019

DolCas Biotech will be debuting MoriKol, a naturally derived, marine-based tripeptide collagen hydrolysate ingredient from kosher, warm-water fish at SupplySide West in Las Vegas. 

DolCas Biotech (Landing, NJ) will be debuting MoriKol, a naturally derived, marine-based tripeptide collagen hydrolysate ingredient from kosher, warm-water fish at SupplySide West in Las Vegas. MoriKol’s proprietary processing method produces a versatile ingredient that is flavorless, odorless, water- and temperature-stable, with a low, clinically supported daily dose of 1 gram.

According to DolCas, MoriKol delivers a minimum of 15% tripeptides, which are a readily utilized form of peptides that are absorbed intact, allowing for the low daily dose. MoriKol also guarantees the delivery of the specific amino acid sequence integral to collagen’s structure, glycine-proline-hydroxyproline (GPH), and showing 3% GPH on assay, states DolCas.

“This is a completely novel ingredient,” explains Shavon Jackson-Michel, ND, director of medical and scientific affairs at DolCas, in a press release. “No US-marketed fish collagen has quantified collagen actives at this level of specificity. Many commercially available collagen hydrolysates require doses between 2.5-10g/day, but offer negligible quantities of bioavailable peptides. Bi- and tripeptides are the smallest absorbable units of collagen, and when provided in a finite amount, provide greater potential for restorative functions, including fibroblast recruitment to damaged areas and collagen formation from bioavailable building blocks.”

The firm also claims that piscine-sourced collagen has a smaller molecular weight compared to porcine or bovine sources of collagen, and that warm water-sourced marine collagen has even better biocompatibility than cold water options such as salmon or cod because it delivers higher levels of the amino acids proline and hydroxyproline.